Search results
FDA Expands Pembrolizumab Approval for Endometrial Cancer
Medscape· 5 days agoThe FDA expanded the approval of pembrolizumab based on improved PFS in patients with advanced or...
US FDA approves Bristol Myers' colorectal cancer therapy
Colorado Springs Gazette· 2 days agoAbout 34% of the patients who were given the combination treatment showed a partial or complete...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 6 days agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer
Clinical Trials Arena via Yahoo Finance· 4 days ago“We have completed enrolment for Cohort Ib of the DENALI study, where we have enrolled more than 100...
Could an FDA-approved cancer drug help stop Parkinson's disease progression?
MedicalNewsToday via AOL· 1 day agoAn existing cancer drug has shown promise in halting Parkinson's disease progression in mouse...
FDA authorizes first menthol-flavored e-cigarettes for adult smokers
ABC 7 Chicago· 1 day agoThe FDA said it authorized four menthol e-cigarettes from Njoy, the vaping brand recently acquired by tobacco giant Altria, which also...longstanding claim that their products ...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks via Yahoo Finance· 4 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face...
FDA approves menthol vapes, drawing criticism from health advocates
Washington Post· 2 days agoThe Food and Drug Administration on Friday approved the first menthol-flavored e-cigarette products,...
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 6 days agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
US FDA puts partial clinical hold on Zentalis’ cancer drug studies; shares drop
WHTC 1450 Holland· 5 days ago(Reuters) - Zentalis Pharmaceuticals said on Tuesday the U.S. Food and Drug Administration has...